North America

Corporate earnings, M&A, IPOs, and business developments across North American markets.

🇺🇸 Aker BP: Second quarter 2026 results

by

🇺🇸 LYSAKER, Norway, July 15, 2026 /PRNewswire/ — Aker BP advanced its strategic growth agenda in the second quarter, combining strong operational delivery with continued maturation of new resources and important milestones across its major development projects. The quarter underlined the… Source: prnewswire Country: United States

🇺🇸 General Motors CEO Mary Barra to be Honored at the Ad Council’s 72nd Annual Public Service Award Dinner

by

🇺🇸 NEW YORK, July 15, 2026 /PRNewswire/ — The Ad Council announced today that Mary Barra, Chair and CEO of General Motors, will be honored at the 72nd annual Public Service Award Dinner on December 3, 2026. Barra will receive the Award for Public Service in recognition of her… Source: prnewswire Country: United States

🇺🇸 International Business Machines Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into International Business Machines (IBM)

by

🇺🇸 IBM investors who relied on the Company’s projected Software and Infrastructure segment growth rates and stability faced losses after IBM reported preliminary second-quarter 2026 results and shares fell nearly 25%. NEW YORK, July 14, 2026 /PRNewswire/ — On July 14, 2026, International… Source: prnewswire Country: United States

🇺🇸 ERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – HBSS

by

🇺🇸 SAN FRANCISCO, July 14, 2026 /PRNewswire/ — Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca’s pan-RAS molecular glue targeting solid tumors… Source: prnewswire Country: United States

🇺🇸 EMBC INVESTOR DEADLINE: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit– HBSS

by

🇺🇸 SAN FRANCISCO, July 14, 2026 /PRNewswire/ — Embecta Corp. (NASDAQ: EMBC) faces a securities class action lawsuit, which seeks to represent investors who purchased or acquired Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit follows the company’s disastrous Q2… Source: prnewswire Country: United States

🇺🇸 BRCB INVESTOR DEADLINE: Black Rock Coffee Bar, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – HBSS

by

🇺🇸 SAN FRANCISCO, July 14, 2026 /PRNewswire/ — Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) faces a securities class action lawsuit related to disclosures the company made to investors within its initial public offering documents whereby it issued about 16.9 million shares to investors at $20… Source: prnewswire Country: United States

🇺🇸 BTU INVESTOR DEADLINE: Peabody Energy Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – HBSS

by

🇺🇸 SAN FRANCISCO, July 14, 2026 /PRNewswire/ — Peabody Energy Corporation (NYSE: BTU) faces a securities class action lawsuit related to surprise disclosures the company made to investors on March 30 and May 5, 2026 about problems with its flagship metallurgical coal asset (“Centurion”)…. Source: prnewswire Country: United States

🇺🇸 INVESTOR DEADLINE ALERT: PicS N.V. (PICS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

by

🇺🇸 Did you buy PICS Class A common stock on or around January 30, 2026? Affected PICS Investor Summary Who: PicS N.V. (NASDAQ: PICS) What: Securities fraud class action lawsuit filed Class Period: pursuant and/or traceable to PicS’s initial public offering (IPO) on or about January 30, 2026… Source: prnewswire Country: United States

🇺🇸 Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis

by

🇺🇸 HANGZHOU, China and SHANGHAI and BOSTON, July 14, 2026 /PRNewswire/ — Lynk Pharmaceuticals Co., Ltd. (“Lynk Pharmaceuticals”), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that patient enrollment was completed on July 9… Source: prnewswire Country: United States

🇺🇸 A THIRD FEDERAL RULING SAYS STIIIZY PRODUCTS DO NOT INFRINGE ON PAX PATENTS

by

🇺🇸 STIIIZY’s new AIO Vape cleared for purchase and sale LOS ANGELES, July 14, 2026 /PRNewswire/ — U.S. Customs and Border Protection (CBP) has ruled that STIIIZY’s redesigned All-In-One (AIO) vape does not infringe on any patents. That means the AIO vape is not subject to the previous… Source: prnewswire Country: United States